Reviews Myobloc


No reviews yet.

Myobloc Drug Description
Myobloc®
(rimabotulinumtoxinB) Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of MYOBLOC and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION



What are the possible side effects of botulinum toxin type B (Myobloc)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these serious side effects, some...
Read All Potential Side Effects for Myobloc »




MYOBLOC ® (rimabotulinumtoxinB) injection is a sterile liquid formulation
of a purified neurotoxin that acts at the neuromuscular junction to produce
flaccid paralysis. The neurotoxin is produced by fermentation of the bacterium
Clostridium botulinum type B (Bean strain) and exists in noncovalent
association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin
complex. The neurotoxin complex is recovered from the fermentation process and
purified through a series of precipitation and chromatography steps.
MYOBLOC is provided as a clear and colorless to light-yellow sterile injectable solution in 3.5-mL glass vials. Each single-use vial of formulated MYOBLOC contains 5,000 Units of botulinum toxin type B per milliliter in 0.05% human serum albumin, 0.01 M sodium succinate, and 0.1 M sodium chloride at approximately pH 5.6.
One unit of MYOBLOC corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specific to Solstice
Neurosciences' manufacture of MYOBLOC. Due to differences in specific details
such as the vehicle, dilution scheme and laboratory protocols for various mouse
LD50 assays, units of biological activity of MYOBLOC cannot be compared to or
converted into units of any other botulinum toxin or any toxin assessed with
any other specific assay method. Therefore, differences in species sensitivities
to different botulinum neurotoxin serotypes preclude extrapolation of animal
dose-activity relationships to human dose estimates. The specific activity of
MYOBLOC ranges between 70 to 130 Units/ng.Last reviewed on RxList: 8/14/2009




Myobloc Drug Description
Myobloc®
(rimabotulinumtoxinB) Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of MYOBLOC and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION



What are the possible side effects of botulinum toxin type B (Myobloc)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these serious side effects, some...
Read All Potential Side Effects for Myobloc »




MYOBLOC ® (rimabotulinumtoxinB) injection is a sterile liquid formulation
of a purified neurotoxin that acts at the neuromuscular junction to produce
flaccid paralysis. The neurotoxin is produced by fermentation of the bacterium
Clostridium botulinum type B (Bean strain) and exists in noncovalent
association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin
complex. The neurotoxin complex is recovered from the fermentation process and
purified through a series of precipitation and chromatography steps.
MYOBLOC is provided as a clear and colorless to light-yellow sterile injectable solution in 3.5-mL glass vials. Each single-use vial of formulated MYOBLOC contains 5,000 Units of botulinum toxin type B per milliliter in 0.05% human serum albumin, 0.01 M sodium succinate, and 0.1 M sodium chloride at approximately pH 5.6.
One unit of MYOBLOC corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specific to Solstice
Neurosciences' manufacture of MYOBLOC. Due to differences in specific details
such as the vehicle, dilution scheme and laboratory protocols for various mouse
LD50 assays, units of biological activity of MYOBLOC cannot be compared to or
converted into units of any other botulinum toxin or any toxin assessed with
any other specific assay method. Therefore, differences in species sensitivities
to different botulinum neurotoxin serotypes preclude extrapolation of animal
dose-activity relationships to human dose estimates. The specific activity of
MYOBLOC ranges between 70 to 130 Units/ng.Last reviewed on RxList: 8/14/2009




Myobloc Drug Description
Myobloc®
(rimabotulinumtoxinB) Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of MYOBLOC and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION



What are the possible side effects of botulinum toxin type B (Myobloc)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these serious side effects, some...
Read All Potential Side Effects for Myobloc »




MYOBLOC ® (rimabotulinumtoxinB) injection is a sterile liquid formulation
of a purified neurotoxin that acts at the neuromuscular junction to produce
flaccid paralysis. The neurotoxin is produced by fermentation of the bacterium
Clostridium botulinum type B (Bean strain) and exists in noncovalent
association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin
complex. The neurotoxin complex is recovered from the fermentation process and
purified through a series of precipitation and chromatography steps.
MYOBLOC is provided as a clear and colorless to light-yellow sterile injectable solution in 3.5-mL glass vials. Each single-use vial of formulated MYOBLOC contains 5,000 Units of botulinum toxin type B per milliliter in 0.05% human serum albumin, 0.01 M sodium succinate, and 0.1 M sodium chloride at approximately pH 5.6.
One unit of MYOBLOC corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specific to Solstice
Neurosciences' manufacture of MYOBLOC. Due to differences in specific details
such as the vehicle, dilution scheme and laboratory protocols for various mouse
LD50 assays, units of biological activity of MYOBLOC cannot be compared to or
converted into units of any other botulinum toxin or any toxin assessed with
any other specific assay method. Therefore, differences in species sensitivities
to different botulinum neurotoxin serotypes preclude extrapolation of animal
dose-activity relationships to human dose estimates. The specific activity of
MYOBLOC ranges between 70 to 130 Units/ng.Last reviewed on RxList: 8/14/2009




Myobloc Drug Description
Myobloc®
(rimabotulinumtoxinB) Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of MYOBLOC and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION



What are the possible side effects of botulinum toxin type B (Myobloc)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these serious side effects, some...
Read All Potential Side Effects for Myobloc »




MYOBLOC ® (rimabotulinumtoxinB) injection is a sterile liquid formulation
of a purified neurotoxin that acts at the neuromuscular junction to produce
flaccid paralysis. The neurotoxin is produced by fermentation of the bacterium
Clostridium botulinum type B (Bean strain) and exists in noncovalent
association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin
complex. The neurotoxin complex is recovered from the fermentation process and
purified through a series of precipitation and chromatography steps.
MYOBLOC is provided as a clear and colorless to light-yellow sterile injectable solution in 3.5-mL glass vials. Each single-use vial of formulated MYOBLOC contains 5,000 Units of botulinum toxin type B per milliliter in 0.05% human serum albumin, 0.01 M sodium succinate, and 0.1 M sodium chloride at approximately pH 5.6.
One unit of MYOBLOC corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specific to Solstice
Neurosciences' manufacture of MYOBLOC. Due to differences in specific details
such as the vehicle, dilution scheme and laboratory protocols for various mouse
LD50 assays, units of biological activity of MYOBLOC cannot be compared to or
converted into units of any other botulinum toxin or any toxin assessed with
any other specific assay method. Therefore, differences in species sensitivities
to different botulinum neurotoxin serotypes preclude extrapolation of animal
dose-activity relationships to human dose estimates. The specific activity of
MYOBLOC ranges between 70 to 130 Units/ng.Last reviewed on RxList: 8/14/2009




Myobloc Drug Description
Myobloc®
(rimabotulinumtoxinB) Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of MYOBLOC and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION



What are the possible side effects of botulinum toxin type B (Myobloc)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these serious side effects, some...
Read All Potential Side Effects for Myobloc »




MYOBLOC ® (rimabotulinumtoxinB) injection is a sterile liquid formulation
of a purified neurotoxin that acts at the neuromuscular junction to produce
flaccid paralysis. The neurotoxin is produced by fermentation of the bacterium
Clostridium botulinum type B (Bean strain) and exists in noncovalent
association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin
complex. The neurotoxin complex is recovered from the fermentation process and
purified through a series of precipitation and chromatography steps.
MYOBLOC is provided as a clear and colorless to light-yellow sterile injectable solution in 3.5-mL glass vials. Each single-use vial of formulated MYOBLOC contains 5,000 Units of botulinum toxin type B per milliliter in 0.05% human serum albumin, 0.01 M sodium succinate, and 0.1 M sodium chloride at approximately pH 5.6.
One unit of MYOBLOC corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specific to Solstice
Neurosciences' manufacture of MYOBLOC. Due to differences in specific details
such as the vehicle, dilution scheme and laboratory protocols for various mouse
LD50 assays, units of biological activity of MYOBLOC cannot be compared to or
converted into units of any other botulinum toxin or any toxin assessed with
any other specific assay method. Therefore, differences in species sensitivities
to different botulinum neurotoxin serotypes preclude extrapolation of animal
dose-activity relationships to human dose estimates. The specific activity of
MYOBLOC ranges between 70 to 130 Units/ng.Last reviewed on RxList: 8/14/2009





Other reviews about Myobloc on wordpress

Botox safety being reviewed by the FDA
  by dennisclifton
WASHINGTON (Reuters) - Regulators said on Friday they were reviewing the safety of Allergan Inc's (AGN.N: Quote, Profile, Research) Botox and a competing product after reports of deaths […]


Death From Botox: Can It Happen To You?
  by marianneguarena
I know a lot of you have probably heard at least one report on the recent deaths of several children after receiving injections of botulinum toxin.  I am […]


Botox: Effective Treatment for Dystonia and Muscle Spasm
  by Yasser Metwally
Botox (botulinum toxin Type A) has been available in the United States for clinical use since 1989. At that time it was approved by the FDA for treatment […]


Botox and Myobloc Linked to Paralysis and Death
  by Dentist.Com
The popular anti-wrinkle drugs Botox and Myobloc have been linked to adverse reactions, including respiratory failure and even death, the US Food and Drug Administration (FDA) warned on […]


Botox Safety Issues
  by Dr. Kenneth Mark
Botox is botulinum, BUT botulinum is not Botox!!!   One of the advantages of practicing in Manhattan, the Hamptons, and Aspen, is that whenever an interesting story hits the news, […]


FDA Requires Boxed Warning for All Botulinum Toxin Products
  by thassodotcom
April 30, 2009 - Prompted by reports of serious adverse events, the U.S. Food and Drug Administration today announced that safety label changes, including a boxed warning, and […]


FDA Requires Boxed Warning for All Botulinum Toxin Products
  by thassodotcom
June 10, 2009 - From a todays' press release by the FDA, we learn the following concerning botulinum toxin products: Prompted by reports of serious adverse events, the American […]


BOTOX® and Botulinum Toxin Products to Bear Black Box Warning
  by englishlifezone
The FDA issued a requirement for black box labeling on Allergan, Inc. Botox® and Botox Cosmetic®, Solstice Neruoscience’s Myobloc®, and Ipsen’s Dysport®, the newest formulation of botulinum toxin. […]


FDA MedWatch - Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
  by irbtipoftheweek
[UPDATED 08/03/2009 from original 04/06/2009 alert] FDA notified healthcare professionals of changes to the established drug names for Botox/Botox Cosmetic, Dysport and Myobloc to reinforce individual potencies and […]



Other reviews about Myobloc on web:

MYOBLOC ® (rimabotulinumtoxinB) Injection is indicated for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position and neck pain associated ... MYOBLOC | Treatment for Cervical Dystonia


Learn about the prescription medication Myobloc (Botulinum Toxin Type B), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Myobloc (Botulinum Toxin Type B) Drug Information: Uses, Side ...


All about Myobloc. View complete and up to date Myobloc information - part of the Drugs.com trusted medication database. Myobloc Facts and Comparisons at Drugs.com


Myobloc™ Clostridium botulinum can be safely and painlessly injected directly in a specific muscle to relax that muscle temporarily. This treatment has been used for many years for ... Education : Procedures : Myobloc


MYOBLOC Reimbursement Services. The Solstice Neurosciences, LLC (“Solstice”) Reimbursement Services* Team uses a case management approach and is available to help educate you ... MYOBLOC Reimbursement Services


Myobloc (rimabotulinumtoxinb) patient information. Detailed drug information for the consumer, includes dosage, Myobloc side effects and more. Myobloc consumer information from Drugs.com


MYOBLOC ™ University is an online professional educational program offered by Solstice Neuroscience, Inc., the maker of Myobloc ® (rimabotulinumtoxinB) Injection Welcome to MYOBLOC University


Drug information and side-effects for Myobloc ... Useful Websites. Medical Tourism Compare and save on surgery Global Translations Myobloc - Drug information from MediLexicon


DESCRIPTION MYOBLOC ® (Botulinum Toxin Type B) Injectable Solution is a sterile liquid formulation of a purified neurotoxin that acts at the neuromuscular junction to produce ... MYOBLOC® (Botulinum Toxin Type B)


Myobloc is a neurotoxin used to reduce the severity of abnormal head position and neck pain associated with neck problems. Side effects and interactions are available at drugstore ... Myobloc - drugstore.com. Low prices, side effects, interactions.





Featured Reviews

Reviews Ranitidine Bismuth Citrate

Tritec Drug Description DRUG DESCRIPTION What are the possible side effects of ranitidine bismuth citrate (Tritec)? Stop taking ranitidine bismuth citrate and seek emergency medical attention if you experience an allergic reaction...
Read More  |  Review This
Reviews Eldepryl

Eldepryl Drug Description ELDEPRYL® (selegiline hydrochloride) DRUG DESCRIPTION What are the possible side effects of selegiline (Eldepryl, Zelapar)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Clindamycin and Benzoyl Peroxide

BenzaClin Drug Description BenzaClin® Topical Gel (clindamycin - benzoyl peroxide) Gel Topical Gel: clindamycin (1%) as clindamycin phosphate, benzoyl peroxide (5%) For Dermatological Use Only - Not for Ophthalmic Use *Reconstitute...
Read More  |  Review This
Reviews Halog Solution

Halog Solution Drug Description HALOG® SOLUTION (halcinonide) Topical Solution, USP 0.1% For Topical Use Only. Not For Ophthalmic Use. DRUG DESCRIPTION What are the possible side effects of halcinonide topical (Halog,...
Read More  |  Review This
Reviews Lopressor HCT

Lopressor HCT Drug Description Lopressor HCT® (metoprolol tartrate and hydrochlorothiazide) Tablet 50/25 Tablets, 100/25 Tablets & 100/50 Tablets Beta Blocker/Diuretic Antihypertensive DRUG DESCRIPTION What are the possible...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....